Rigel Pharmaceuticals (RIGL) Earnings Date, Estimates & Call Transcripts

$1.12
-0.01 (-0.88%)
(As of 04/24/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

RIGL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RIGL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Rigel Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($0.03)($0.01)($0.02) 
Q2 20242($0.04)($0.03)($0.04) 
Q3 20242($0.10)($0.03)($0.07) 
Q4 20242($0.02)$0.02$0.00 
FY 20248($0.19)($0.05)($0.12) 
Q1 20251$0.01$0.01$0.01 
Q2 20251$0.00$0.00$0.00 
Q3 20251$0.02$0.02$0.02 
Q4 20251$0.04$0.04$0.04 
FY 20254$0.07$0.07 $0.07

RIGL Earnings Date and Information

Rigel Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off prior year's report dates.

Rigel Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/7/2024
Estimated)
------- 
11/7/2023Q3 2023($0.07)($0.03)+$0.04($0.03)$27.83 million$28.13 million    
8/1/2023Q2 2023($0.08)($0.04)+$0.04($0.04)$26.02 million$26.89 million    
5/2/2023Q1 2023($0.09)($0.08)+$0.01($0.08)$24.29 million$26.07 million
3/7/2023Q4 2022($0.07)$0.01+$0.08$0.01$37.55 million$51.28 million    
11/3/2022Q3 2022($0.13)($0.11)+$0.02($0.11)$22.76 million$22.41 million
8/2/2022Q2 2022($0.12)($0.08)+$0.04($0.08)$23.56 million$29.82 million
5/3/2022Q1 2022($0.12)($0.16)($0.04)($0.16)$18.49 million$16.74 million    
3/1/2022Q4 2021($0.13)($0.13)-($0.13)$21.20 million$20.41 million    
11/2/2021Q3 2021($0.10)($0.12)($0.02)($0.12)$24.16 million$21.54 million    
8/3/2021Q2 2021($0.11)($0.08)+$0.03($0.08)$22.08 million$26.27 million    
5/5/2021Q1 2021$0.01$0.22+$0.21$0.22$40.06 million$81.02 million  

Rigel Pharmaceuticals Earnings - Frequently Asked Questions

When is Rigel Pharmaceuticals's earnings date?

Rigel Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off last year's report dates. Learn more on RIGL's earnings history.

How much revenue does Rigel Pharmaceuticals generate each year?

Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded annual revenue of $116.88 million.

How much profit does Rigel Pharmaceuticals generate each year?

Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded net income of -$25.09 million. RIGL has generated -$0.15 earnings per share over the last four quarters.

What is Rigel Pharmaceuticals's EPS forecast for next year?

Rigel Pharmaceuticals's earnings are expected to grow from ($0.05) per share to $0.05 per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:RIGL) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners